ArticleCell death discovery2024

LARP4B promotes hepatocellular carcinoma progression and impairs sorafenib efficacy by activating SPINK1-mediated EGFR pathway.

Chuanxu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.